Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
South Korea
· Delayed Price · Currency is KRW 28,950
-450 (-1.53%)
Mar 9, 2026, 3:30 PM KST
Daihan Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 170,226 | 154,056 | 163,170 | 183,600 | 172,200 | 197,700 | Upgrade
|
| Market Cap Growth | 11.56% | -5.59% | -11.13% | 6.62% | -12.90% | 4.11% | Upgrade
|
| Enterprise Value | 84,025 | 80,167 | 60,093 | 96,028 | 117,564 | 155,174 | Upgrade
|
| Last Close Price | 28950.00 | 25333.88 | 25919.62 | 27814.69 | 25531.67 | 28903.95 | Upgrade
|
| PE Ratio | 5.39 | 4.56 | 5.74 | 7.36 | 7.60 | 11.38 | Upgrade
|
| PS Ratio | 0.81 | 0.75 | 0.83 | 1.00 | 1.00 | 1.19 | Upgrade
|
| PB Ratio | 0.58 | 0.56 | 0.66 | 0.82 | 0.85 | 1.09 | Upgrade
|
| P/TBV Ratio | 0.58 | 0.56 | 0.66 | 0.82 | 0.85 | 1.09 | Upgrade
|
| P/FCF Ratio | 40.46 | 7.76 | 9.28 | 9.01 | 5.99 | 6.99 | Upgrade
|
| P/OCF Ratio | 5.25 | 4.32 | 4.20 | 6.33 | 4.24 | 5.88 | Upgrade
|
| EV/Sales Ratio | 0.40 | 0.39 | 0.31 | 0.52 | 0.69 | 0.93 | Upgrade
|
| EV/EBITDA Ratio | 1.89 | 1.77 | 1.35 | 2.28 | 2.90 | 3.76 | Upgrade
|
| EV/EBIT Ratio | 2.31 | 2.11 | 1.68 | 2.91 | 4.04 | 5.18 | Upgrade
|
| EV/FCF Ratio | 19.97 | 4.04 | 3.42 | 4.71 | 4.09 | 5.49 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | - | 0.03 | 0.12 | 0.16 | Upgrade
|
| Debt / EBITDA Ratio | 0.00 | 0.00 | - | 0.15 | 0.58 | 0.70 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.00 | - | 0.32 | 0.82 | 1.02 | Upgrade
|
| Net Debt / Equity Ratio | -0.29 | -0.28 | -0.42 | -0.40 | -0.36 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.94 | -1.70 | -2.35 | -2.16 | -1.80 | -0.94 | Upgrade
|
| Net Debt / FCF Ratio | -20.49 | -3.89 | -5.94 | -4.47 | -2.53 | -1.37 | Upgrade
|
| Asset Turnover | 0.64 | 0.66 | 0.69 | 0.67 | 0.65 | 0.66 | Upgrade
|
| Inventory Turnover | 4.68 | 5.36 | 5.38 | 5.46 | 5.22 | 5.03 | Upgrade
|
| Quick Ratio | 2.76 | 2.58 | 3.28 | 3.04 | 2.72 | 2.47 | Upgrade
|
| Current Ratio | 3.55 | 3.22 | 3.87 | 3.65 | 3.20 | 3.10 | Upgrade
|
| Return on Equity (ROE) | 11.24% | 12.89% | 12.01% | 11.66% | 11.79% | 9.97% | Upgrade
|
| Return on Assets (ROA) | 6.91% | 7.69% | 7.83% | 7.50% | 6.91% | 7.49% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.76% | 17.74% | 19.93% | 18.62% | 15.86% | 16.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 12.10% | 13.50% | 14.20% | 14.10% | 12.80% | 14.00% | Upgrade
|
| Earnings Yield | 18.54% | 21.91% | 17.42% | 13.59% | 13.16% | 8.79% | Upgrade
|
| FCF Yield | 2.47% | 12.88% | 10.77% | 11.10% | 16.71% | 14.30% | Upgrade
|
| Payout Ratio | 16.46% | 12.82% | 13.20% | 8.45% | 9.30% | 12.13% | Upgrade
|
| Buyback Yield / Dilution | - | - | 1.75% | 0.25% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.